Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Stroke ; 16(4): 466-475, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-32536328

RESUMEN

BACKGROUND: The Melbourne Mobile Stroke Unit (MSU) is the first Australian service to provide prehospital acute stroke treatment, including thrombolysis and facilitated triage for endovascular thrombectomy. AIMS: To estimate the cost-effectiveness of the MSU during the first full year of operation compared with standard ambulance and hospital stroke care pathways (standard care). METHODS: The costs and benefits of the Melbourne MSU were estimated using an economic simulation model. Operational costs and service utilization data were obtained from the MSU financial and patient tracking reports. The health benefits were estimated as disability-adjusted life years (DALYs) avoided using local data on reperfusion therapy and estimates from the published literature on their effectiveness. Costs were presented in Australian dollars. The robustness of results was assessed using multivariable (model inputs varied simultaneously: 10,000 Monte Carlo iterations) and various one-way sensitivity analyses. RESULTS: In 2018, the MSU was dispatched to 1244 patients during 200 days of operation. Overall, 167 patients were diagnosed with acute ischemic stroke, and 58 received thrombolysis, endovascular thrombectomy, or both. We estimated 27.94 DALYs avoided with earlier access to endovascular thrombectomy (95% confidence interval (CI) 15.30 to 35.93) and 16.90 DALYs avoided with improvements in access to thrombolysis (95% CI 9.05 to 24.68). The MSU was estimated to cost an additional $30,982 per DALY avoided (95% CI $21,142 to $47,517) compared to standard care. CONCLUSIONS: There is evidence that the introduction of MSU is cost-effective when compared with standard care due to earlier provision of reperfusion therapies.


Asunto(s)
Isquemia Encefálica , Accidente Cerebrovascular , Australia , Isquemia Encefálica/tratamiento farmacológico , Análisis Costo-Beneficio , Humanos , Accidente Cerebrovascular/tratamiento farmacológico , Terapia Trombolítica
2.
J Clin Neurosci ; 10(4): 502-6, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12852898

RESUMEN

Only eight cases of spinal cord ischaemic stroke causing paraplegia with associated vertebral body infarction have been previously described. We describe a ninth case with histopathology confirming the Magnetic Resonance Imaging (MRI) appearance of vertebral body infarction. We have reviewed the literature concerning this condition and discuss its diagnosis and aetiology.


Asunto(s)
Vértebras Cervicales/patología , Infarto/complicaciones , Isquemia/complicaciones , Accidente Cerebrovascular/complicaciones , Anciano , Asma/complicaciones , Vértebras Cervicales/diagnóstico por imagen , Vértebras Cervicales/cirugía , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Humanos , Infarto/diagnóstico por imagen , Infarto/cirugía , Isquemia/diagnóstico por imagen , Isquemia/cirugía , Angiografía por Resonancia Magnética , Imagen por Resonancia Magnética , Fusión Vertebral , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/cirugía , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA